259 related articles for article (PubMed ID: 29987915)
1. Antipsychotic drugs and risk of newly diagnosed tuberculosis in schizophrenia.
Liu HC; Hung GC; Yang SY; Liao YT; Pan CH; Chen CC; Kuo CJ
Psychiatry Clin Neurosci; 2018 Oct; 72(10):789-800. PubMed ID: 29987915
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study.
Hung GC; Liu HC; Yang SY; Pan CH; Liao YT; Chen CC; Kuo CJ
J Clin Psychiatry; 2016 Jan; 77(1):60-6. PubMed ID: 26613551
[TBL] [Abstract][Full Text] [Related]
3. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
Kuo CJ; Yang SY; Liao YT; Chen WJ; Lee WC; Shau WY; Chang YT; Tsai SY; Chen CC
Schizophr Bull; 2013 May; 39(3):648-57. PubMed ID: 22282455
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
Yang SY; Liao YT; Liu HC; Chen WJ; Chen CC; Kuo CJ
J Clin Psychiatry; 2013 Jan; 74(1):e79-86. PubMed ID: 23419234
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic medications and the progression of upper respiratory infection to pneumonia in patients with schizophrenia.
Chang CK; Chen PH; Pan CH; Su SS; Tsai SY; Chen CC; Kuo CJ
Schizophr Res; 2020 Aug; 222():327-334. PubMed ID: 32507380
[TBL] [Abstract][Full Text] [Related]
8. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J
Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447
[TBL] [Abstract][Full Text] [Related]
9. Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland.
Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
Nord J Psychiatry; 2017 Oct; 71(7):496-502. PubMed ID: 28632422
[TBL] [Abstract][Full Text] [Related]
10. Estimating the Risk of Pneumonia in Patients With Schizophrenia Newly Receiving Clozapine: A Nationwide Cohort Study.
Wu CS; Chen TY; Tsai SY; Chen CC; Kuo CJ
J Clin Psychopharmacol; 2019; 39(4):297-304. PubMed ID: 31188233
[TBL] [Abstract][Full Text] [Related]
11. Association between antipsychotic use and risk of acute myocardial infarction: a nationwide case-crossover study.
Lin ST; Chen CC; Tsang HY; Lee CS; Yang P; Cheng KD; Li DJ; Wang CJ; Hsieh YC; Yang WC
Circulation; 2014 Jul; 130(3):235-43. PubMed ID: 24838361
[TBL] [Abstract][Full Text] [Related]
12. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.
Scheltema Beduin AA; Swets M; Machielsen M; Korver N;
J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156
[TBL] [Abstract][Full Text] [Related]
13. Comparative effect of antipsychotics on risk of self-harm among patients with schizophrenia.
Ma CH; Chang SS; Tsai HJ; Gau SS; Chen IM; Liao SC; Chien YL; Hsieh MH; Wu CS
Acta Psychiatr Scand; 2018 Apr; 137(4):296-305. PubMed ID: 29430641
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
[TBL] [Abstract][Full Text] [Related]
15. Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.
Rajkumar AP; Horsdal HT; Wimberley T; Cohen D; Mors O; Børglum AD; Gasse C
Am J Psychiatry; 2017 Jul; 174(7):686-694. PubMed ID: 28103712
[TBL] [Abstract][Full Text] [Related]
16. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
Wu CS; Wang SC; Yeh IJ; Liu SK
J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
[TBL] [Abstract][Full Text] [Related]
17. [Treatment-resistant schizophrenia: Neutropenia with olanzapine and clozapine, and stabilization with two depot antipsychotics].
Alba P
Vertex; 2017 Mar; 28(132):141-144. PubMed ID: 29522636
[TBL] [Abstract][Full Text] [Related]
18. Temporal trends in clozapine use at time of discharge among people with schizophrenia at two public psychiatric hospitals in Taiwan, 2006-2017.
Lin CH; Chan HY; Hsu CC; Chen FC
Sci Rep; 2020 Oct; 10(1):17984. PubMed ID: 33093511
[TBL] [Abstract][Full Text] [Related]
19. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
Ollendorf DA; Joyce AT; Rucker M
MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
[TBL] [Abstract][Full Text] [Related]
20. Use of atypical antipsychotics and risks of cataract development in patients with schizophrenia: A population-based, nested case-control study.
Chou PH; Chu CS; Lin CH; Cheng C; Chen YH; Lan TH; Huang MW
Schizophr Res; 2016 Jul; 174(1-3):137-143. PubMed ID: 27061658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
